½ÃÀ庸°í¼­
»óǰÄÚµå
1383106

¼¼°èÀÇ ÇØºÎÇÐÀû ¸ðµ¨¸µ ½ÃÀå ¿¹Ãø(-2030³â)

Anatomical Modelling Market Research Report Forecast till 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Market Research Future | ÆäÀÌÁö Á¤º¸: ¿µ¹® 128 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÇØºÎÇÐÀû ¸ðµ¨¸µ ½ÃÀå ±Ô¸ð´Â Á¶»ç ±â°£ µ¿¾È ¿¬Æò±Õ 3.21%ÀÇ °ÇÀüÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀåÀº 3D ÇÁ¸°ÆÃ Çõ½ÅÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú ÀÓ»ó ºÎ¹®ÀÇ R&D ¹ßÀü°ú °°Àº º¯¼ö¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

Áö¿ªº° ÀλçÀÌÆ®

ºÏ¹Ì ½ÃÀåÀÌ 2022³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

À¯·´ ½ÃÀåÀº ±â¼ú Çõ½ÅÀÇ ÁøÀü µîÀ¸·Î ÀÎÇØ µÎ ¹øÂ°·Î Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀÌ 2023-2030³â °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, Àεµ´Â ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ °¡Àå ºü¸£°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è ÇØºÎÇÐÀû ¸ðµ¨¸µ ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÏ¿© ½ÃÀå ¿ªÇÐ, Áö¿ª ¹× ºÎ¹® ºÐ¼®, ±â¾÷ °³¿ä µîÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ¼­·Ð

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • °³¿ä
  • ¼ºÀå ÃËÁø¿äÀÎ
    • 3D ÇÁ¸°ÆÃ ±â¼úÀÇ ±Þ¼ÓÇÑ ¼ºÀå
    • ÀÇ·á ºÎ¹®ÀÇ ¿¬±¸°³¹ß ÀÌ´Ï¼ÅÆ¼ºê È®´ë
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·
    • °Å¾×ÀÇ ÀÚº» ÅõÀÚ¿Í °æ¿µ ºñ¿ë
  • ±âȸ
    • ±³À° ºÎ¹®¿¡¼­ ÇØºÎÇÐÀû ¸ðµ¨ ¼ö¿ä Áõ°¡

Á¦5Àå ½ÃÀå ¿äÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
    • ¿¬±¸°³¹ß
    • Á¦Á¶
    • À¯Åë°ú ÆÇ¸Å
    • ÆÇ¸ÅÈÄ ¸ð´ÏÅ͸µ
  • Porter's Five Forces ºÐ¼® ¸ðµ¨
  • ¼¼°èÀÇ ÇØºÎÇÐÀû ¸ðµ¨¸µ ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ
    • °ø±Þ¸Á¿¡ ´ëÇÑ ¿µÇâ
    • °¡°Ý¿¡ ´ëÇÑ ¿µÇâ
    • ÁÖ¿ä ±â¾÷¿¡ ´ëÇÑ ¿µÇâ

Á¦6Àå ¼¼°èÀÇ ÇØºÎÇÐÀû ¸ðµ¨¸µ ½ÃÀå : À¯Çüº°

  • °³¿ä
  • Á¦Ç°
    • µÎ°³°ñ, ³ú¸ðµ¨, ½Å°æ°è ¸ðµ¨
    • °ñ°Ý, ±ÙÀ° ¸ðµ¨
    • ½ÉÀå, ¼øÈ¯±â°è ¸ðµ¨
    • ¼ÒÈ­±â°è ¸ðµ¨
    • µ¿Ã¼, Àå±â ¸ðµ¨
    • Ä¡¾Æ, ÅÎ ¸ðµ¨
    • ÀӽЏðµ¨
    • ÇǺΠ¸ðµ¨
    • µ¿¹° ¸ðµ¨
    • ±âŸ
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦7Àå ¼¼°èÀÇ ÇØºÎÇÐÀû ¸ðµ¨¸µ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
  • º´¿ø, Áø·á¼Ò
  • µ¿¹° Ŭ¸®´Ð
  • Çмú±â°ü, ±³À° ¼¾ÅÍ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÇØºÎÇÐÀû ¸ðµ¨¸µ ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª
    • Áßµ¿
    • ¾ÆÇÁ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«

Á¦9Àå °æÀï »óȲ

  • °³¿ä
  • °æÀï º¥Ä¡¸¶Å·
  • ¼¼°èÀÇ ÇØºÎÇÐÀû ¸ðµ¨¸µ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå Àü·«
  • ¼¼°èÀÇ ÇØºÎÇÐÀû ¸ðµ¨¸µ ½ÃÀåÀÇ °³¹ß¼ö ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ¹ßÀü ºÐ¼®
  • ÁÖ¿ä ¹ßÀü°ú ¼ºÀå Àü·«
    • Á¦Ç° ¹ß¸Å
    • ÇÕº´/Àμö
  • À繫 ¸ÅÆ®¸¯½º
    • ÆÇ¸Å·®(2022³â)
    • ¿¬±¸°³¹ß ÁöÃâ(2022³â)

Á¦10Àå ±â¾÷ °³¿ä

  • 3D SYSTEMS, INC.
  • GPI ANATOMICALS
  • STRATASYS
  • 3B SCIENTIFIC
  • LAERDAL MEDICAL
  • NASCO HEALTHCARE
  • JAVELIN TECHNOLOGIES INC.
  • ALGEOS LTD.
  • ERLER ZIMMER GMBH & CO. KG
  • ALTAY SCIENTIFIC

Á¦11Àå ºÎ·Ï

ksm 23.12.01

Modelling Overview

Anatomical Modelling Market is projected to register a healthy CAGR of 3.21% during the review period.

This market is being driven by a couple of variables, remembering the fast development for 3D printing innovation, and the developing Research and development drives in the clinical area. Furthermore, the developing interest for anatomical models from the instructive area will give potential learning experiences to the market from here on out.

As of late, fast development in 3D printing innovation because of its plan exactness, minimal expense quick prototyping, great coordination, speedy remaking, and item wellbeing. Furthermore, 3D printing innovation is really used to create 3D anatomical models for clinical understudies, specialists, and other clinical experts to give important understanding to treatment or careful preparation and assist with accomplishing the best results for the patient.

Moreover, the market players are associated with item dispatches, key arrangements, and acquisitions to increase their market positions. For example, In November 2020, Emerge NV (Belgium) sent off Imitates VR Watcher for clinical preparation, schooling, and correspondence. It permits doctors to address more perplexing cases through customized arranging.

Market Segmentation

The market segmentation for Anatomical Modelling comprises software, services, and products based on their type.

Hospitals and clinics, veterinary clinics, educational institutions and centers, and other establishments are included in the end-user segmentation of the anatomy modeling market.

Regional Insights

The North America anatomical demonstrating market represented the biggest piece of the pie in 2022. The significant explanations for this huge offer are the developing progressions in the training area, expanding interest for trend setting innovation for leading medical procedures, and the developing interest of government experts in changing medical services schooling foundation. Instructive and research focuses, for example, the US Clinical Center utilize 3D printing to produce anatomic models that help specialists and care staff to design techniques.

Europe anatomical demonstrating market represented the second-biggest piece of the pie because of innovation progressions, change in showing methods, developing interest for remote educating and practice meetings across various nations. Moreover, the Germany anatomical displaying supplier ascribed to hold the biggest piece of the pie, and the France anatomical demonstrating suppliers is extended be the quickest developing business sector in the Europe region.

The Asia-Pacific anatomical demonstrating market is supposed to be the quickest developing from 2023 to 2030 because of the developing reception of instructive apparatuses for conveying successful life structures teachers, developing interest in medical services framework, expanding foundation of clinical schools, and rising interest in overhauling careful offices. Additionally, China anatomical demonstrating accounted to hold the biggest piece of the pie, and the India anatomical displaying is projected to be the quickest developing business sector in the Asia-Pacific region.

Major Players

Key Companies in the anatomical modelling market include 3D Systems Inc. (US), Stratasys (Israel), GPI Anatomicals (US), Laerdal Medical (Norway), 3B Scientific (Germany), Javelin Technologies Inc. (Canada), Nasco Healthcare (US), Algeos Ltd. (UK), Erler Zimmer GmbH & Co. KG (Germany), and Altay Scientific (UK).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVESYSTEM
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 RAPID GROWTH IN 3D PRINTING TECHNOLOGY
    • 4.2.2 GROWING R&D INITIATIVES IN THE MEDICAL SECTOR
  • 4.3 RESTRAINTS
    • 4.3.1 SHORTAGE OF SKILLED PROFESSIONALS
    • 4.3.2 HIGH CAPITAL INVESTMENT AND OPERATING COSTS
  • 4.4 OPPORTUNITY
    • 4.4.1 GROWING DEMAND FOR ANATOMICAL MODELS FROM THE EDUCATIONAL SECTOR

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL ANATOMICAL MODELLING MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON PRICING
    • 5.3.3 IMPACT ON KEY PLAYERS

6 GLOBAL ANATOMICAL MODELLING MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 PRODUCT
    • 6.2.1 SKULL, BRAIN MODEL & NERVOUS SYSTEMS MODEL
    • 6.2.2 SKELETON & MUSCLE MODEL
    • 6.2.3 HEART AND CIRCULATORY SYSTEMS MODEL
    • 6.2.4 DIGESTIVE SYSTEMS MODEL
    • 6.2.5 TORSO AND ORGANS MODEL
    • 6.2.6 DENTAL, JAW AND TEETH MODEL
    • 6.2.7 PREGNANCY MODEL
    • 6.2.8 SKIN MODEL
    • 6.2.9 VETERINARY MODELS
    • 6.2.10 OTHERS
  • 6.3 SOFTWARE
  • 6.4 SERVICES

7 GLOBAL ANATOMICAL MODELLING MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 HOSPITALS & CLINICS
  • 7.3 VETERINARY CLINICS
  • 7.4 ACADEMIC INSTITUTIONS & EDUCATION CENTERS
  • 7.5 OTHERS

8 GLOBAL ANATOMICAL MODELLING MARKET, BY REGION

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 US
    • 8.2.2 CANADA
  • 8.3 EUROPE
    • 8.3.1 GERMANY
    • 8.3.2 UK
    • 8.3.3 FRANCE
    • 8.3.4 ITALY
    • 8.3.5 SPAIN
    • 8.3.6 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 CHINA
    • 8.4.2 INDIA
    • 8.4.3 JAPAN
    • 8.4.4 SOUTH KOREA
    • 8.4.5 AUSTRALIA
    • 8.4.6 REST OF ASIA-PACIFIC
  • 8.5 REST OF THE WORLD
    • 8.5.1 MIDDLE EAST
    • 8.5.2 AFRICA
    • 8.5.3 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 COMPETITIVE BENCHMARKING
  • 9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL ANATOMICAL MODELLING MARKET
  • 9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL ANATOMICAL MODELLING MARKET
  • 9.5 KEY DEVELOPMENT ANALYSIS
  • 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.6.1 PRODUCT LAUNCH
    • 9.6.2 MERGER/ACQUISITION
  • 9.7 FINANCIAL MATRIX
    • 9.7.1 SALES (USD MILLION), 2022
    • 9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

10 COMPANY PROFILES

  • 10.1 3D SYSTEMS, INC.
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 PRODUCTS/SERVICES OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 GPI ANATOMICALS
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCTS/SERVICES OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 SWOT ANALYSIS
    • 10.2.6 KEY STRATEGIES
  • 10.3 STRATASYS
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS/SERVICES OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 SWOT ANALYSIS
    • 10.3.6 KEY STRATEGIES
  • 10.4 3B SCIENTIFIC
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS/SERVICES OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 SWOT ANALYSIS
    • 10.4.6 KEY STRATEGIES
  • 10.5 LAERDAL MEDICAL
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS/SERVICES OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 KEY STRATEGIES
  • 10.6 NASCO HEALTHCARE
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS/SERVICES OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 KEY STRATEGIES
  • 10.7 JAVELIN TECHNOLOGIES INC.
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS/SERVICES OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 KEY STRATEGIES
  • 10.8 ALGEOS LTD.
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 PRODUCTS/SERVICES OFFERED
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 KEY STRATEGIES
  • 10.9 ERLER ZIMMER GMBH & CO. KG
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS/SERVICES OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 SWOT ANALYSIS
    • 10.9.6 KEY STRATEGIES
  • 10.10 ALTAY SCIENTIFIC
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS/SERVICES OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 KEY STRATEGIES

11 APPENDIX

  • 11.1 REFERENCES
  • 11.2 RELATED REPORTS
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦